Skip to main content
OpenTrials
Completed

NCT Number: NCT01337726

Combined Illness Management and Psychotherapy in Treating Depressed Elders

The purpose of this research study is to test a program developed to help patients with chronic heart or lung problems take care of themselves and cope with their illness or limitations.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Depression Behavior Behavioral Symptoms Cardiovascular Diseases Chronic Disease Chronic Obstructive Pulmonary Disease Disease Attributes Heart Diseases Heart Failure Lung Diseases Lung Diseases, Obstructive Pathologic Processes Pathological Conditions, Signs and Symptoms Pulmonary Disease, Chronic Obstructive Respiratory Tract Diseases

Age range

55 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Iowa City VA Health Care System, Iowa City, Iowa, United States

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 55 years or older
  • Diagnosis of Heart Failure or COPD
  • Depressive symptoms indicated by a BDI-II score of 10 or higher
  • Functional impairment

Exclusion criteria

  • Current psychotherapy
  • Cognitive Impairment
  • Psychiatric diagnosis
  • Active suicidal thoughts
  • Significant vision or hearing impairment
  • Residence in long term care facility

Treatment and study plan

Combined Psychotherapy and Illness Management

Behavioral

Participants will have 10 weekly visits with a study clinician at their home and by phone. They will focus on their self care and illness management as well as how to manage their mood/cope emotionally. Follow up assessments will occur at 26 and 52 weeks.

Illness Management Only

Behavioral

Participants in this group will have 10 weekly sessions with a study clinician at home and by phone. They will focus only on how they manage their illness. Follow up assessments will occur at 26 and 52 weeks.

Primary outcomes

  1. Reduction in depressive symptoms

    Time frame: 10 weeks

    Change from Baseline in depressive symtoms at 10 weeks

Secondary outcomes

  1. Improvement in quality of life/functioning

    Time frame: 10 weeks

    Change from Baseline in quality of life/functioning at 10 weeks

Sponsors and collaborators

Lead sponsor

University of Iowa

Other

Collaborators

  • National Institute of Mental Health (NIMH)

Registry information

Acronym: COPE

Important dates

Study start
2011
Primary completion
2016
Study completion
2016
First posted
Apr 19, 2011
Registry last updated
Apr 5, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.